Steven A. Cohen
Steven A. Cohen is a billionaire hedge fund investor and founder of SAC Capital Partners. He has been referred to as "A New Prince of Wall Street" by the New York Times and "The Hedge Fund King" by the Wall Street Journal. According to Forbes, he has an estimated net worth of $6.8 billion.
Cohen attended the Wharton School at the University of Pennsylvania and was hired as a junior trader at Gruntal & Co. in 1978. On his first day, he made an $8,000 profit, and eventually was making around $100,000 a day for the company.
SAC Capital Partners is a hedge fund based in Stamford, Connecticut. It was founded in 1992 by Cohen with $25 million but now currently manages $14 billion. The fund is very active accounting for about 3 percent of the NYSE's daily volume and 1 percent of the NASDAQ's daily volume. The fund's favorite industries include technology, retail/consumer goods, and healthcare.
View Older Stories View More Recent Stories
-
Steve Cohen And Other Hedge Fund Titans Shift To Cash Amid Turmoil
-
Cohen's SAC Capital Boosts Stake in United Therapeutics (UTHR) to 7.4%
-
Cohen's SAC Capital Discloses 3% Stake in James River Coal (JRCC)
-
Cohen's SAC Capital Accumulates Stakes in Target (TGT), Pilgrim's Pride (PPC) and Some Financials (STI, FITB, STT)
-
Cohen's SAC Capital Cuts Stake in Invitrogen (IVGN) to 5.3%
-
Ron Insana To Close Up Shop And Head To SAC Capital
-
Cohen's SAC Capital Boosts Stake in Incyte (INCY) to 6.4%
-
Cohen's SAC Capital Raises Stake in Invitrogen (IVGN) from 5.2% to 6.9%
-
Cohen's SAC Capital Cuts Stake in Barrier Therapeutics (BTRX) to 1.21%
-
Who's Talk Was Louder on Lehman (LEH) Today - Bill Gross or Ben Bernanke?
-
SAC Capital Still Trading With Lehman (LEH) - Bloomberg
-
Cohen's SAC Capital Discloses 8% Stake in Barrier Therapeutics (BTRX), Files 13D
-
Cohen's SAC Capital Accumulates 5.1% Stake in Inspire Pharmaceuticals (ISPH)
-
Cohen's SAC Capital Boosts Stake in Akorn (AKRX) to 5.6%
-
Cohen's SAC Capital Discloses 5.2% Stake in Invitrogen (IVGN), Supports Merger With Applera
-
Cohen's SAC Capital Discloses 5% Stake in Navistar (NAV)
-
UPDATE: Cohen's SAC Capital Accumulates 5.3% Stake In Takeover Target Take-Two Interactive (TTWO)
-
Cohen's SAC Capital Files 13D On Take-Two Interactive (TTWO) Showing 5.3% Stake
-
Cohen's SAC Capital Builds 6.1% Stake in Emergency Medical Services (EMS)
-
Cohen's SAC Capital Accumulates 7.1% Stake in Sanderson Farms (SAFM)
-
Cohen's SAC Capital Discloses 7.6% Stake in Pilgrims Pride (PPC)
-
Buy Orient-Express (OEH) on Potential Takeover Target -Barron's
-
Cohen's SAC Capital Boosts Stake in Fresh Del Monte (FDP) to 5.1%.
-
Cohen's SAC Capital Accumulates 6.8% Stake in Cardiome Pharma (CRME)
-
D. E. Shaw Boosts "Active" Stake in Orient-Express Hotels (OEH) to 7.6%
-
Cohen's SAC Capital Discloses Nearly 5% Stake in Willbros Group (WG)
-
Cohen's SAC Capital Boosts Stake in Stewart Enterprises (STEI) to Nearly 6%
-
Has The Fear Factor Made Ethanol Stocks A Bargain? (PEIX, AVR, VSE, GPRE)
-
What's Steven Cohen's SAC Capital Buying? A Few Banks Among Other Things (BK, C)
-
Cohen's SAC Capital Discloses 5.5% Stake in Orient-Express Hotels (OEH), Express Concerns About Share Structure
-
Cohen's S.A.C. Capital Discloses 6.3% Stake in Barrier Therapeutics (BTRX)
-
Cohen's SAC Capital Boosts Stake in Chiquita Brands (CQB) to 5.4%
-
Cohen's SAC Capital Disclosese 4.6% Stake in Auto Parts Maker Tenneco (TEN)
-
Cohen's SAC Capital Accumulates 6.3% Stake in Hasbro (HAS)
-
Cohen's SAC Capital Builds 5% Stake in Jean Maker True Religion (TRLG)
-
Cohen's SAC Capital Lowers Stake in Assisted Living Concepts (ALC) to 4.2%
-
Cohen's SAC Discloses 5.1% Stake in Applied Bio (ABI); Wants Celera Seperated, CEO Gone and All Options Explored
-
Cohen's SAC Capital Accumulates 7.6% Stake in PF Chang's (PFCB)
-
HealthCor Discloses 5.6% Stake in Affymax (AFFY)
-
Corel (CREL) Receives Offer from Majority Shareholder for $11; SAC Capital's Steve Cohen Hired to Special Committee for Responding to Proposal
-
Cohen's SAC Capital Discloses 5% Stake in Auxilium Pharmaceuticals (AUXL)
-
Following Steven Cohen: Century Aluminum (CENX) May Be Headed to $75
-
Cohen's SAC Capital Discloses 4.1% Stake in Xenoport (XNPT)
-
Cohen's SAC Capital Moves Out of Pharmion (PHRM)
-
Following Dan Loeb: Mylan (MYL) - A Cheap Drug To Own
-
Cohen's SAC Capital Wants A Higher Bid for Pharmion (PHRM)
-
Cohen's SAC Capital Accumulates 8.3% Stake in Orexigen Therapeutics (OREX)
-
Cohen's SAC Capital Discloses 5.1% Stake in Albermarle (ALB)
-
Cohen's SAC Capital Discloses 8.9% Stake in Assured Guaranty Ltd. (AGO)
-
Cohen's SAC Capital Discloses 7.7% Stake in Takeover Target VistaCare (VSTA)

